{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:54:17Z","timestamp":1790610857937,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Hubei Province","award":["2020CFB873"],"award-info":[{"award-number":["2020CFB873"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03873-4","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T04:56:25Z","timestamp":1749185785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic value of neutrophil-to-lymphocyte ratio and CA 19\u20139 in overall survival of patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy"],"prefix":"10.1186","volume":"23","author":[{"given":"Yanli","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanhe","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengyi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengwei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"issue":"12","key":"3873_CR1","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","volume":"17","author":"J Franko","year":"2016","unstructured":"Franko J, Shi Q, Meyers JP, Maughan TS, Adams RA, Seymour MT, Saltz L, Punt CJA, Koopman M, Tournigand C, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive system (ARCAD) database. Lancet Oncol. 2016;17(12):1709\u201319.","journal-title":"Lancet Oncol"},{"issue":"3","key":"3873_CR2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/codi.13593","volume":"19","author":"CE Klaver","year":"2017","unstructured":"Klaver CE, Groenen H, Morton DG, Laurberg S, Bemelman WA, Tanis PJ, research committee of the European Society of C. Recommendations and consensus on the treatment of peritoneal metastases of colorectal origin: a systematic review of national and international guidelines. Colorectal Dis. 2017;19(3):224\u201336.","journal-title":"Colorectal Dis"},{"issue":"2","key":"3873_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00384-014-2085-6","volume":"30","author":"MA Elferink","year":"2015","unstructured":"Elferink MA, de Jong KP, Klaase JM, Siemerink EJ, de Wilt JH. Metachronous metastases from colorectal cancer: a population-based study in North-East Netherlands. Int J Colorectal Dis. 2015;30(2):205\u201312.","journal-title":"Int J Colorectal Dis"},{"key":"3873_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ejca.2015.09.017","volume":"53","author":"PH Cashin","year":"2016","unstructured":"Cashin PH, Mahteme H, Spang N, Syk I, Frodin JE, Torkzad M, Glimelius B, Graf W. Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: a randomised trial. Eur J Cancer. 2016;53:155\u201362.","journal-title":"Eur J Cancer"},{"issue":"2","key":"3873_CR5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Quenet","year":"2021","unstructured":"Quenet F, Elias D, Roca L, Goere D, Ghouti L, Pocard M, Facy O, Arvieux C, Lorimier G, Pezet D, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(2):256\u201366.","journal-title":"Lancet Oncol"},{"key":"3873_CR6","doi-asserted-by":"crossref","unstructured":"Narasimhan V, Britto M, Pham T, Warrier S, Naik A, Lynch AC, Michael M, Tie J, Ramsay R, Heriot A. Evolution of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: 8-year single-institutional experience. Dis Colon Rectum.  2019;62(10):1195\u20131203.","DOI":"10.1097\/DCR.0000000000001456"},{"issue":"3","key":"3873_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","volume":"30","author":"J Franko","year":"2012","unstructured":"Franko J, Shi Q, Goldman CD, Pockaj BA, Nelson GD, Goldberg RM, Pitot HC, Grothey A, Alberts SR, Sargent DJ. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol. 2012;30(3):263\u20137.","journal-title":"J Clin Oncol"},{"issue":"4","key":"3873_CR8","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1245\/s10434-016-5698-x","volume":"24","author":"C Ihemelandu","year":"2017","unstructured":"Ihemelandu C, Sugarbaker PH. Management for peritoneal metastasis of colonic origin: role of cytoreductive surgery and perioperative intraperitoneal chemotherapy: a single institution\u2019s experience during two decades. Ann Surg Oncol. 2017;24(4):898\u2013905.","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"3873_CR9","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/ans.13152","volume":"86","author":"N Alzahrani","year":"2016","unstructured":"Alzahrani N, Ferguson JS, Valle SJ, Liauw W, Chua T, Morris DL. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: long-term results at St George Hospital, Australia. ANZ J Surg. 2016;86(11):937\u201341.","journal-title":"ANZ J Surg"},{"issue":"1","key":"3873_CR10","first-page":"72","volume":"7","author":"J Esquivel","year":"2016","unstructured":"Esquivel J. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: survival outcomes and patient selection. J Gastrointest Oncol. 2016;7(1):72\u20138.","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"3873_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/DCR.0000000000002315","volume":"65","author":"MS Parikh","year":"2022","unstructured":"Parikh MS, Johnson P, Romanes JP, Freitag HE, Spring ME, Garcia-Henriquez N, Monson JRT. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: a systematic review. Dis Colon Rectum. 2022;65(1):16\u201326.","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"3873_CR12","doi-asserted-by":"publisher","first-page":"e379","DOI":"10.1016\/j.surge.2020.11.002","volume":"19","author":"D Solomon","year":"2021","unstructured":"Solomon D, Leigh N, Bekhor E, Feferman Y, Dhorajiya P, Feingold D, Hofstedt M, Aycart SN, Golas BJ, Sarpel U, et al. The role of molecular biomarkers in outcomes and patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases of colorectal origin. Surgeon. 2021;19(6):e379\u201385.","journal-title":"Surgeon"},{"issue":"5","key":"3873_CR13","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1245\/s10434-014-3985-y","volume":"22","author":"JM Baumgartner","year":"2015","unstructured":"Baumgartner JM, Tobin L, Heavey SF, Kelly KJ, Roeland EJ, Lowy AM. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2015;22(5):1716\u201321.","journal-title":"Ann Surg Oncol"},{"key":"3873_CR14","first-page":"2495131","volume":"2016","author":"JL Ng","year":"2016","unstructured":"Ng JL, Ong WS, Chia CS, Tan GH, Soo KC, Teo MC. Prognostic relevance of the peritoneal surface disease severity score compared to the peritoneal cancer index for colorectal peritoneal carcinomatosis. Int J Surg Oncol. 2016;2016:2495131.","journal-title":"Int J Surg Oncol"},{"issue":"1","key":"3873_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12957-019-1602-z","volume":"17","author":"L Solaini","year":"2019","unstructured":"Solaini L, D\u2019Acapito F, Passardi A, Framarini M, Tauceri F, Di Pietrantonio D, Frassineti GL, Casadei Gardini A, Cucchetti A, Cavaliere D, et al. Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study. World J Surg Oncology. 2019;17(1):58.","journal-title":"World J Surg Oncology"},{"issue":"4","key":"3873_CR16","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/annonc\/mdw012","volume":"27","author":"T Grenader","year":"2016","unstructured":"Grenader T, Waddell T, Peckitt C, Oates J, Starling N, Cunningham D, Bridgewater J. Prognostic value of neutrophil-to-lymphocyte ratio in advanced oesophago-gastric cancer: exploratory analysis of the REAL-2 trial. Annals of oncology\u202f: official journal of the European Society for Medical Oncology. 2016;27(4):687\u201392.","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology"},{"issue":"7","key":"3873_CR17","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.21037\/tlcr-23-7","volume":"12","author":"M Sung","year":"2023","unstructured":"Sung M, Jang WS, Kim HR, Park JA, Lim SM, Kim HR, Cho BC, Park YR, Hong MH. Prognostic value of baseline and early treatment response of neutrophil-lymphocyte ratio, C-reactive protein, and lactate dehydrogenase in non-small cell lung cancer patients undergoing immunotherapy. Translational lung cancer research. 2023;12(7):1506\u201316.","journal-title":"Translational lung cancer research"},{"issue":"4","key":"3873_CR18","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1093\/annonc\/mdy004","volume":"29","author":"E Dell\u2019Aquila","year":"2018","unstructured":"Dell\u2019Aquila E, Cremolini C, Zeppola T, Lonardi S, Bergamo F, Masi G, Stellato M, Marmorino F, Schirripa M, Urbano F, et al. Prognostic and predictive role of neutrophil\/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO. Annals of oncology\u202f: official journal of the European Society for Medical Oncology. 2018;29(4):924\u201330.","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology"},{"issue":"18","key":"3873_CR19","doi-asserted-by":"publisher","first-page":"5264","DOI":"10.7150\/jca.46446","volume":"11","author":"Q Yan","year":"2020","unstructured":"Yan Q, Ertao Z, Zhimei Z, Weigang D, Jianjun P, Jianhui C, Chuangqi C. Systemic immune-inflammation index (SII): a more promising inflammation-based prognostic marker for patients with synchronic colorectal peritoneal carcinomatosis. J Cancer. 2020;11(18):5264\u201372.","journal-title":"J Cancer"},{"key":"3873_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.suronc.2020.09.002","volume":"35","author":"Y Zager","year":"2020","unstructured":"Zager Y, Hoffman A, Dreznik Y, Jacoby H, Cordoba M, Horesh N, Nevler A, Gutman M, Berger Y. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer: the prognostic impact of baseline neutrophil-lymphocyte, platelet-lymphocyte and lymphocyte-monocyte ratios. Surg Oncol. 2020;35:321\u20137.","journal-title":"Surg Oncol"},{"issue":"3","key":"3873_CR21","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/SLA.0000000000001743","volume":"265","author":"JC Chan","year":"2017","unstructured":"Chan JC, Chan DL, Diakos CI, Engel A, Pavlakis N, Gill A, Clarke SJ. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer. Ann Surg. 2017;265(3):539\u201346.","journal-title":"Ann Surg"},{"issue":"4","key":"3873_CR22","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/jso.21068","volume":"98","author":"AG Portilla","year":"2008","unstructured":"Portilla AG, Shigeki K, Dario B, Marcello D. The intraoperative staging systems in the management of peritoneal surface malignancy. J Surg Oncol. 2008;98(4):228\u201331.","journal-title":"J Surg Oncol"},{"issue":"4","key":"3873_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1470-2045(04)01425-1","volume":"5","author":"O Glehen","year":"2004","unstructured":"Glehen O, Mohamed F, Gilly FN. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol. 2004;5(4):219\u201328.","journal-title":"Lancet Oncol"},{"issue":"Suppl 3","key":"3873_CR24","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1245\/s10434-021-10905-2","volume":"28","author":"T Jastrzebski","year":"2021","unstructured":"Jastrzebski T, Goscinski M. HIPEC in complementary treatment to cytoreductive procedures: an unexplained issue after the PRODIGE 7 trial. Ann Surg Oncol. 2021;28(Suppl 3):803\u20135.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"3873_CR25","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1245\/s10434-019-07255-5","volume":"26","author":"KJ Kelly","year":"2019","unstructured":"Kelly KJ, Alsayadnasser M, Vaida F, Veerapong J, Baumgartner JM, Patel S, Ahmad S, Barone R, Lowy AM. Does primary tumor side matter in patients with metastatic colon cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy? Ann Surg Oncol. 2019;26(5):1421\u20137.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"3873_CR26","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1245\/s10434-019-07374-z","volume":"26","author":"C Munoz-Zuluaga","year":"2019","unstructured":"Munoz-Zuluaga C, King MC, Sardi A, Ledakis P, Sittig M, Nieroda C, MacDonald R, Gushchin V. Selection and characteristics of patients with peritoneal dissemination from appendiceal cancer with exceptional\/poor survival after CRS\/HIPEC. Ann Surg Oncol. 2019;26(7):2268\u201375.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"3873_CR27","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/jso.24290","volume":"114","author":"IS Froysnes","year":"2016","unstructured":"Froysnes IS, Larsen SG, Spasojevic M, Dueland S, Flatmark K. Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis in Norway: prognostic factors and oncologic outcome in a national patient cohort. J Surg Oncol. 2016;114(2):222\u20137.","journal-title":"J Surg Oncol"},{"issue":"1","key":"3873_CR28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1245\/s10434-015-4627-8","volume":"23","author":"M Faron","year":"2016","unstructured":"Faron M, Macovei R, Goere D, Honore C, Benhaim L, Elias D. Linear relationship of peritoneal cancer index and survival in patients with peritoneal metastases from colorectal cancer. Ann Surg Oncol. 2016;23(1):114\u20139.","journal-title":"Ann Surg Oncol"},{"key":"3873_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/JIR.S391932","volume":"16","author":"A Misiewicz","year":"2023","unstructured":"Misiewicz A, Dymicka-Piekarska V. Fashionable, but what is their real clinical usefulness? NLR, LMR, and PLR as a promising indicator in colorectal cancer prognosis: a systematic review. J Inflamm Res. 2023;16:69\u201381.","journal-title":"J Inflamm Res"},{"key":"3873_CR30","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ijsu.2018.06.037","volume":"56","author":"LX Zhang","year":"2018","unstructured":"Zhang LX, Wei ZJ, Xu AM, Zang JH. Can the neutrophil-lymphocyte ratio and platelet-lymphocyte ratio be beneficial in predicting lymph node metastasis and promising prognostic markers of gastric cancer patients? Tumor maker retrospective study. Int J Surg. 2018;56:320\u20137.","journal-title":"Int J Surg"},{"issue":"6","key":"3873_CR31","first-page":"4100","volume":"15","author":"Z Shi","year":"2023","unstructured":"Shi Z, Zheng D, Tang X, Du Y. Correlation of immune inflammatory indices and nutritional risk index with prognosis in patients with non-small cell lung cancer. American journal of translational research. 2023;15(6):4100\u20139.","journal-title":"American journal of translational research"},{"issue":"18","key":"3873_CR32","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.3390\/jcm10184198","volume":"10","author":"JH Sim","year":"2021","unstructured":"Sim JH, Lee JS, Jang DM, Kim HJ, Lee SW, Cho HS, Choi WJ. Effects of perioperative inflammatory response in cervical cancer: laparoscopic versus open surgery. Journal of clinical medicine. 2021;10(18):4198.","journal-title":"Journal of clinical medicine"},{"key":"3873_CR33","doi-asserted-by":"publisher","first-page":"1105587","DOI":"10.3389\/fonc.2022.1105587","volume":"12","author":"P Rottier","year":"2022","unstructured":"Rottier P, Emile G, Johnson A, Levy C, Allouache D, Hrab I, Segura C, Morel A, Villemin M, Dubot-Poitelon C, et al. Pretreatment neutrophil to lymphocyte ratio as prognostic factor in metastatic breast cancer treated with cyclin dependent kinase 4\/6 inhibitors. Front Oncol. 2022;12:1105587.","journal-title":"Front Oncol"},{"key":"3873_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1205897","volume":"10","author":"Q Chen","year":"2023","unstructured":"Chen Q, Li GL, Zhu HQ, Yu JD, Chen ZP, Wu JY, Lin ZY, Wan YL. The neutrophil-to-lymphocyte ratio and lactate dehydrogenase combined in predicting liver metastasis and prognosis of colorectal cancer. Front Med. 2023;10: 1205897.","journal-title":"Front Med"},{"key":"3873_CR35","doi-asserted-by":"publisher","first-page":"9631","DOI":"10.2147\/CMAR.S222756","volume":"11","author":"X Li","year":"2019","unstructured":"Li X, Guo D, Chu L, Huang Y, Zhang F, Li W, Chen J. Potential diagnostic value of combining inflammatory cell ratios with carcinoembryonic antigen for colorectal cancer. Cancer management and research. 2019;11:9631\u201340.","journal-title":"Cancer management and research"},{"issue":"5","key":"3873_CR36","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/02656736.2017.1384073","volume":"34","author":"K Rangarajan","year":"2018","unstructured":"Rangarajan K, Chandrakumaran K, Dayal S, Mohamed F, Moran BJ, Cecil TD. The pre-operative neutrophil-lymphocyte ratio predicts overall and disease-free survival following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with pseudomxyoma peritonei of appendiceal origin. International journal of hyperthermia\u202f: the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2018;34(5):559\u201363.","journal-title":"International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group"},{"issue":"6","key":"3873_CR37","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.21037\/jgo.2019.01.36","volume":"10","author":"SY Yang","year":"2019","unstructured":"Yang SY, Kang JH, Kim HS, Han YD, Min BS, Lee KY. Status of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Journal of gastrointestinal oncology. 2019;10(6):1251\u201365.","journal-title":"Journal of gastrointestinal oncology"},{"issue":"4","key":"3873_CR38","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1245\/s10434-016-5693-2","volume":"24","author":"C Ihemelandu","year":"2017","unstructured":"Ihemelandu C. Inflammation-based prognostic scores: utility in prognostication and patient selection for cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal metastasis of colonic origin. Ann Surg Oncol. 2017;24(4):884\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"3873_CR39","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10147-017-1092-3","volume":"22","author":"TSH Bong","year":"2017","unstructured":"Bong TSH, Tan GHC, Chia C, Soo KC, Teo MCC. Preoperative platelet-lymphocyte ratio is an independent prognostic marker and superior to carcinoembryonic antigen in colorectal peritoneal carcinomatosis patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Clin Oncol. 2017;22(3):511\u20138.","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"3873_CR40","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1245\/s10434-022-12736-1","volume":"30","author":"A El Asmar","year":"2023","unstructured":"El Asmar A, Delcourt M, Kamden L, Khaled C, Bohlok A, Moreau M, Sclafani F, Donckier V, Liberale G. Prognostic value of preoperative serological biomarkers in patients undergoing curative-intent cytoreductive surgery for colorectal cancer peritoneal metastases. Ann Surg Oncol. 2023;30(3):1863\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"3873_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13045-023-01407-7","volume":"16","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Li X, Wang Y, Wei Y, Wei X. Involvement of inflammasomes in tumor microenvironment and tumor therapies. J Hematol Oncol. 2023;16(1):24.","journal-title":"J Hematol Oncol"},{"issue":"7","key":"3873_CR42","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/DCR.0000000000001076","volume":"61","author":"O Aziz","year":"2018","unstructured":"Aziz O, Jaradat I, Chakrabarty B, Selvasekar CR, Fulford PE, Saunders MP, Renehan AG, Wilson MS, O\u2019Dwyer ST. Predicting survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendix adenocarcinoma. Dis Colon Rectum. 2018;61(7):795\u2013802.","journal-title":"Dis Colon Rectum"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03873-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03873-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03873-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T06:01:44Z","timestamp":1749189704000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03873-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3873"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03873-4","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"3 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the ethics committee of Hubei cancer hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The informed consent of this study has been obtained from patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"220"}}